NASDAQ : LENZ
LENZ Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.05 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 95.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
LENZ Therapeutics, Inc. (LENZ) reported revenue of 12.36M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 12.36M | 19.09M | 15.00M | |||
| Cost of Revenue | 2.23M | 418.00K | ||||
| Gross Profit | 10.13M | 18.67M | 15.00M | |||
| Selling, General & Admin | 159.82M | 91.14M | 28.81M | 12.93M | 4.36M | 2.47M |
| Research & Development | 18.67M | 29.80M | 59.50M | 21.12M | 4.22M | |
| Operating Expenses | 159.82M | 109.81M | 58.61M | 72.43M | 25.48M | 6.69M |
| Operating Income | -149.69M | -91.14M | -58.61M | -72.43M | -10.48M | -6.69M |
| Interest & Investment Income | 9.88M | 9.76M | 8.55M | 2.19M | 4.00K | |
| Other Non Operating Income (Expenses) | -463.00K | -243.00K | 289.00K | 93.00K | 15.00K | -869.00K |
| Pretax Income | -140.27M | -81.62M | -49.77M | -70.15M | -10.46M | -7.56M |
| Income Tax Expense | 5.00K | 502.00K | 1.00K | -179.00K | 347.00K | |
| Net Income | -140.27M | -82.13M | -49.77M | -69.97M | -10.81M | -7.56M |
| Net Income to Common | -140.27M | -82.13M | -49.77M | -69.97M | -10.81M | -7.56M |
| Shares Outstanding (Basic) | 31.31M | 28.81M | 21.28M | 1.96M | 9.46M | 9.36M |
| Shares Outstanding (Diluted) | 31.31M | 28.81M | 21.28M | 1.96M | 9.46M | 9.36M |
| EPS (Basic) | -4.48 | -2.85 | -2.34 | -35.71 | -1.14 | -0.81 |
| EPS (Diluted) | -4.48 | -2.85 | -2.34 | -35.71 | -1.14 | -0.81 |
| Free Cash Flow | -70.00M | -59.86M | -60.41M | -4.13M | -5.40M | |
| Free Cash Flow Per Share | -2.43 | -2.81 | -30.84 | -0.44 | -0.58 | |
| Gross Margin | 81.97% | 97.81% | 100.00% | |||
| Operating Margin | -1,211.17% | -477.46% | -69.89% | |||
| Profit Margin | -1,134.97% | -430.25% | -72.07% | |||
| Free Cash Flow Margin | -366.71% | -27.52% | ||||
| EBITDA | -149.25M | -90.85M | -58.55M | -72.41M | -10.47M | -6.69M |
| EBITDA Margin | -69.83% | |||||
| D&A For EBITDA | 437.00K | 287.00K | 58.00K | 15.00K | 8.00K | 2.00K |
| EBIT | -149.69M | -91.14M | -58.61M | -72.43M | -10.48M | -6.69M |
| EBIT Margin | -69.89% | |||||
| Revenue as Reported | 12.36M | 19.09M | 15.00M | |||
| Advertising Expenses | 8.00M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 25.18M | 20.16M | 35.14M | 44.44M | 18.31M | |
| Short-Term Investments | 267.17M | 188.87M | 30.65M | |||
| Cash & Short-Term Investments | 220.00M | 292.35M | 209.03M | 65.79M | 44.44M | 18.31M |
| Accounts Receivable | 329.00K | |||||
| Other Receivables | 2.10M | 1.10M | ||||
| Receivables | 2.43M | 1.10M | ||||
| Inventory | 2.94M | |||||
| Prepaid Expenses | 3.70M | 1.67M | 1.45M | 2.20M | 16.00K | |
| Restricted Cash | 114.00K | |||||
| Total Current Assets | 301.41M | 211.92M | 67.24M | 46.64M | 18.32M | |
| Property, Plant & Equipment | 1.92M | 1.99M | 372.00K | 279.00K | 10.00K | |
| Long-Term Deferred Charges | 2.74M | |||||
| Other Long-Term Assets | 2.54M | 1.40M | 21.00K | 31.00K | 2.00K | |
| Total Assets | 305.88M | 215.30M | 70.38M | 46.95M | 18.34M | |
| Accounts Payable | 4.17M | 4.26M | 5.71M | 4.75M | 460.00K | |
| Accrued Expenses | 16.55M | 5.58M | 12.67M | 4.29M | 793.00K | |
| Current Portion of Leases | 465.00K | 567.00K | 137.00K | 103.00K | ||
| Current Income Taxes Payable | 347.00K | |||||
| Total Current Liabilities | 21.19M | 10.41M | 18.51M | 9.50M | 1.25M | |
| Long-Term Leases | 350.00K | 814.00K | 192.00K | 147.00K | ||
| Other Long-Term Liabilities | 121.00K | 66.00K | ||||
| Total Liabilities | 21.54M | 11.22M | 18.83M | 9.71M | 1.25M | |
| Common Stock | 1.00K | 1.00K | 5.91M | 5.91M | 5.90M | |
| Additional Paid-In Capital | 511.24M | 348.90M | 2.52M | 1.10M | 251.00K | |
| Retained Earnings | -227.14M | -145.01M | -95.25M | -25.28M | -14.47M | |
| Comprehensive Income & Other | 242.00K | 196.00K | 6.00K | |||
| Total Common Equity | 219.26M | 284.34M | 204.08M | -86.81M | -18.27M | -8.31M |
| Shareholders' Equity | 219.26M | 284.34M | 204.08M | 51.55M | 37.24M | 17.08M |
| Total Liabilities & Equity | 305.88M | 215.30M | 70.38M | 46.95M | 18.34M | |
| Total Debt | 569.00K | 815.00K | 1.38M | 329.00K | 250.00K | |
| Net Cash (Debt) | 219.43M | 291.53M | 207.65M | 65.47M | 44.19M | 18.31M |
| Net Cash Per Share | 7.01 | 10.12 | 9.76 | 33.42 | 4.67 | 1.96 |
| Filing Date Shares Outstanding | 31.42M | 31.35M | 27.54M | 25.53M | 9.63M | 9.36M |
| Total Common Shares Outstanding | 31.42M | 31.34M | 27.52M | 9.74M | 9.63M | 9.36M |
| Working Capital | 280.23M | 201.51M | 48.73M | 37.14M | 17.07M | |
| Book Value Per Share | 6.98 | 9.07 | 7.42 | -8.91 | -1.90 | -0.89 |
| Tangible Book Value | 219.26M | 284.34M | 204.08M | -86.81M | -18.27M | -8.31M |
| Tangible Book Value Per Share | 6.98 | 9.07 | 7.42 | -8.91 | -1.90 | -0.89 |
| Machinery | 663.00K | 475.00K | 69.00K | 51.00K | 15.00K | |
| Leasehold Improvements | 108.00K | 100.00K | 12.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -82.13M | -49.77M | -69.97M | -10.81M | -7.56M | |
| Depreciation & Amortization | 287.00K | 58.00K | 15.00K | 8.00K | 2.00K | |
| Loss (Gain) From Sale of Assets | 16.00K | |||||
| Asset Writedown & Restructuring Costs | 82.00K | |||||
| Loss (Gain) From Sale of Investments | -3.21M | -5.35M | -1.06M | |||
| Stock-Based Compensation | 12.55M | 6.37M | 1.34M | 721.00K | 196.00K | |
| Other Operating Activities | 1.05M | -123.00K | -21.00K | 819.00K | ||
| Change in Accounts Receivable | -329.00K | |||||
| Change in Inventory | -4.28M | |||||
| Change in Accounts Payable | -90.00K | -4.28M | 856.00K | 4.29M | 382.00K | |
| Change in Other Net Operating Assets | 7.95M | -7.48M | 8.55M | 1.72M | 770.00K | |
| Operating Cash Flow | -69.17M | -59.39M | -60.38M | -4.09M | -5.39M | |
| Capital Expenditures | -827.00K | -468.00K | -30.00K | -37.00K | -9.00K | |
| Investment in Securities | -74.84M | -154.01M | -29.59M | |||
| Investing Cash Flow | -75.67M | -154.48M | -29.62M | -37.00K | -9.00K | |
| Issuance of Common Stock | 149.75M | 83.55M | 203.00K | 129.00K | ||
| Other Financing Activities | 115.45M | -2.48M | ||||
| Financing Cash Flow | 149.75M | 199.00M | 80.70M | 30.26M | 22.77M | |
| Net Cash Flow | 4.91M | -14.87M | -9.30M | 26.13M | 17.36M | |
| Free Cash Flow | -70.00M | -59.86M | -60.41M | -4.13M | -5.40M | |
| Free Cash Flow Margin | -366.71% | -27.52% | ||||
| Free Cash Flow Per Share | -2.43 | -2.81 | -30.84 | -0.44 | -0.58 | |
| Levered Free Cash Flow | -40.25M | -40.65M | -34.21M | 99.12K | ||
| Unlevered Free Cash Flow | -40.25M | -40.65M | -34.21M | 99.12K | ||
| Change in Working Capital | 3.25M | -11.76M | 9.41M | 6.01M | 1.15M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 95.83M | 500.64M | 793.95M | |||
| Enterprise Value | -123.60M | 299.42M | 578.42M | |||
| Last Close Price | 3.05 | 16.00 | 28.87 | |||
| PS Ratio | 7.75 | 26.23 | ||||
| PB Ratio | 0.44 | 1.76 | 3.89 | |||
| P/TBV Ratio | 0.44 | 1.76 | 3.89 | |||
| EV/Sales Ratio | 15.69 | |||||
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.00 | -1.02 | -1.02 | -1.27 | -1.19 | -1.07 |
| Net Debt / EBITDA Ratio | 1.47 | 3.21 | 3.55 | 0.90 | 4.22 | 2.74 |
| Net Debt / FCF Ratio | 4.17 | 3.47 | 1.08 | 10.71 | 3.39 | |
| Asset Turnover | 0.07 | 0.46 | ||||
| Quick Ratio | 13.91 | 20.19 | 3.55 | 4.68 | 14.61 | |
| Current Ratio | 14.23 | 20.36 | 3.63 | 4.91 | 14.62 | |
| Return on Equity (ROE) | -33.63% | -38.94% | -157.61% | -39.80% | ||
| Return on Assets (ROA) | -21.86% | -25.64% | -77.17% | -20.07% | ||
| Return on Capital Employed (ROCE) | -32.00% | -28.60% | -139.70% | -28.00% | -39.20% | |
| Earnings Yield | -146.88% | -16.40% | -6.27% | |||
| FCF Yield | -119.40% | -13.98% | -7.54% | |||
| Buyback Yield / Dilution | -12.13% | -35.39% | -986.27% | 79.28% | -1.05% |